MarketLens

What Does Stopping GLP-1 Treatment Really Mean for Your Heart

7 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

Already a Pro member? Log in

SHARE THIS ON:

What Does a CEO's Stock Purchase Really Mean for Investors

7 months ago

What Does High Short Interest Really Mean for a Stock

8 months ago

Is the GLP-1 Price War Escalating, and What Does it Mean for Eli Lilly

8 months ago

What Does the Glaukos CFO's Stock Sale Really Mean for Investors

7 months ago

Employers Pepsi, Starbucks and Cigna Are Dropping GLP-1 Coverage. At 65, Medicare May Cover Zepbound for Sleep Apnea or Wegovy for Heart Risk, With Part D Spending Capped at $2,400 in 2027

PepsiCo, Starbucks, and Cigna cut employee GLP-1 weight-loss coverage, shifting focus to Medicare, where Part D coverage for Zepbound or Wegovy depends on diagnosis and caps spending at $2,400 in 2027...

PEP

Stock News•2 weeks ago

Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation

Fractyl Health's Revita met the six-month co-primary endpoint in the REMAIN-1 pivotal study with p=0.0023, showing 80% retention of GLP-1-induced weight loss versus 67% for sham after GLP-1 discontinu...

GLP

Stock News•2 months ago

GLP-1 weight loss drugs effective even at low starter doses

GLP-1 obesity drugs showed weight loss at low starter doses, with significantly less nausea than at higher doses, per a new study. Patients staying on low doses may trade reduced efficacy for improved...

GLP